Patents Assigned to BRISTOL-MYERS SQUIBB COMAPANY
  • LACTAMS AS INHIBITORS OF ROCK
    Publication number: 20180044326
    Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.
    Type: Application
    Filed: March 8, 2016
    Publication date: February 15, 2018
    Applicant: Bristol-Myers Squibb Comapany
    Inventors: Peter W. Glunz, Doree F. Sitkoff, Mandar Shrikrishna Bodas, Navnath Dnyanoba Yadav, Sharanabasappa Patil, Prasanna Savanor Maddu Rao
  • FUSED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION
    Publication number: 20100256180
    Abstract: Disclosed are fused heterocyclic compounds of Formula (I): or pharmaceutically-acceptable salts or stereoisomers thereof. Also disclosed are methods of using such compounds in the treatment of at least one androgen receptor-associated condition, such as, for example, cancer, and pharmaceutical compositions comprising such compounds.
    Type: Application
    Filed: October 31, 2008
    Publication date: October 7, 2010
    Applicant: BRISTOL-MYERS SQUIBB COMAPANY
    Inventors: Weifang Shan, James Aaron Balog, Ashvinikumar V. Gavai, Yufen Zhao